We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002304:SZSEJiangsu Yanghe Distillery Co., Ltd. Analysis

Data as of 2026-07-22 - not real-time

CN¥40.83

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Jiangsu Yanghe is trading at CNY 40.83, just above its 20‑day SMA of 39.14 but still below the 50‑day SMA of 41.89, indicating short‑term resilience amid a longer‑term bearish backdrop. The MACD histogram is positive and the MACD line sits above its signal, while volume is on an upward trend, suggesting a modest near‑term upside; however, 30‑day volatility is high at 32% and the market sentiment is in “Extreme Greed” territory (fear‑greed index 90.3).
Fundamentally, the company posted a 26% revenue decline and negative operating and free cash flow, though it maintains a strong cash pile (CNY 22.3 bn) and low debt (debt‑to‑equity 0.43). Profit margins are thin (6.2%) and ROE is only 2%, while the trailing PE of 60.9 is starkly above the forward PE of 19.5, implying current pricing is stretched. The dividend yield of 3.65% looks attractive, but a payout ratio of 344% raises sustainability concerns. Analysts’ median target of CNY 52.5 points to roughly 28% upside, but the mix of high valuation, weak cash generation and regulatory exposure in China’s liquor sector tempers enthusiasm.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Positive MACD histogram and price above 20‑day SMA
  • Increasing trading volume supporting near‑term demand
  • Support level near CNY 37.29 providing downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue contraction and negative cash flow limiting earnings growth
  • Valuation gap to analyst target price suggesting modest upside
  • High dividend yield offset by unsustainable payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong brand presence in China’s premium liquor market
  • Potential regulatory tightening on alcohol production and marketing
  • Robust balance sheet with ample cash and low leverage

Key Metrics & Analysis

Financial Health

Revenue Growth-26.00%
Profit Margin6.22%
P/E Ratio60.9
ROE1.98%
ROA1.67%
Debt/Equity0.43
P/B Ratio1.2
Op. Cash FlowCN¥-1360069632
Free Cash FlowCN¥-1973422080

Technical Analysis

TrendBearish
RSI53.1
SupportCN¥37.29
ResistanceCN¥41.87
MA 20CN¥39.14
MA 50CN¥41.89
MA 200CN¥55.21
MACDBullish
VolumeIncreasing
Fear & Greed Index90.3

Valuation

Target PriceCN¥52.21
Upside/Downside27.87%
GradeFair
TypeBlend
Dividend Yield3.65%

Risk Assessment

Beta0.19
Volatility32.00%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.